Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 560

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 560
---
| 8.6           |     | Notices                                        |     | A-52      |
| 8.7           |     | Governing Law and Venue; Waiver of Jury Trial  |     | A-53      |
| 8.8           |     | Descriptive Headings                           |     | A-53      |
| 8.9           |     | Parties in Interest                            |     | A-53      |
| 8.10          |     | Certain Definitions                            |     | A-53      |
| 8.11          |     | Specific Performance                           |     | A-61      |
| 8.12          |     | Interpretation                                 |     | A-62      |
| 8.13          |     | Disclosure Schedules                           |     | A-62      |
| 8.14          |     | Counterparts                                   |     | A-62      |

Annex A-iii AGREEMENT AND PLAN OF MERGER THIS AGREEMENT OF MERGER AND PLAN OF REORGANIZATION (this “ Agreement ”), dated as of November 4, 2024 (the “ Signing Date ”), is by and among KADIMASTEM LTD., an Israeli publicly traded company limited by shares (the “ Company ”), NLS PHARMACEUTICS LTD., a corporation incorporated under the laws of Switzerland (the “ Parent ”), NLS PHARMACEUTICS (ISRAEL) LTD., an Israeli company and a wholly owned subsidiary of Parent (the “ Merger Sub ”). Terms not otherwise defined herein shall have the meanings ascribed to such terms in Section 8.10 of this Agreement. RECITALS WHEREAS, the respective boards of directors of Parent (the “ Parent Board ”), Merger Sub (the “ Merger Sub Board ”) and the Company (the “ Company Board ”) have approved, and declared advisable, fair to and in the best interests of such entity and its respective shareholders, this Agreement and the transactions contemplated by this Agreement, including the merger of Merger Sub with and into the Company, with the Company surviving as a wholly owned Subsidiary of Parent (the “ Merger ”), upon the terms and subject to the conditions set forth in this Agreement and in accordance with the provisions of Sections 314 – 327 of the Companies Law 5759-1999 of the State of Israel (together with the rules and regulations thereunder, the “ ICL ”); WHEREAS